ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 80 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,347,395 | -36.3% | 196,700 | -3.6% | 0.03% | -30.4% |
| Q2 2023 | $2,116,237 | -44.9% | 204,073 | -57.0% | 0.05% | -41.8% |
| Q1 2023 | $3,838,244 | +1038.9% | 474,443 | +2374.4% | 0.08% | +618.2% |
| Q2 2021 | $337,000 | -36.3% | 19,174 | -8.6% | 0.01% | -45.0% |
| Q1 2021 | $529,000 | +58.9% | 20,981 | -59.2% | 0.02% | +66.7% |
| Q4 2020 | $333,000 | +2461.5% | 51,461 | +339.8% | 0.01% | +1100.0% |
| Q3 2019 | $13,000 | -97.6% | 11,700 | -43.5% | 0.00% | -98.9% |
| Q3 2017 | $535,000 | +52.9% | 20,711 | +60.3% | 0.09% | +21.9% |
| Q2 2017 | $350,000 | -62.8% | 12,920 | -59.0% | 0.07% | -58.3% |
| Q1 2017 | $940,000 | +256.1% | 31,545 | +224.8% | 0.18% | +191.7% |
| Q4 2016 | $264,000 | – | 9,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,858,569 | $85,243,000 | 25.08% |
| Sofinnova Management VIII, L.L.C. | 1,539,480 | $45,907,000 | 24.21% |
| EcoR1 Capital, LLC | 673,100 | $20,072,000 | 5.07% |
| Cormorant Asset Management, LP | 800,000 | $23,856,000 | 3.46% |
| Perceptive Advisors | 1,260,847 | $37,598,000 | 2.14% |
| NEXTHERA CAPITAL LP | 111,500 | $3,325,000 | 1.70% |
| Foresite Capital Management III, LLC | 140,000 | $4,175,000 | 1.60% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $5,964,000 | 1.41% |
| Rock Springs Capital Management LP | 675,000 | $20,129,000 | 1.16% |
| CAXTON CORP | 13,263 | $395,000 | 1.13% |